DTP Vaccines Market 2024 - By Size, Share, Growth Rate, Emerging Trends, Development Status, Revenue Outlook And Forecast 2033

The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

DTP Vaccines Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $8.63 billion In 2028 At A CAGR Of 7.1% :

The dtp vaccines market size has grown strongly in recent years. It will grow from $6.13 billion in 2023 to $6.56 billion in 2024 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to increase in healthcare access, continuous protection towards infectious diseases and rising awareness of immunization.

The dtp vaccines market size is expected to see strong growth in the next few years. It will grow to $8.63 billion in 2028 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to strong late-stage pipeline and new drug approvals, increased healthcare expenditure and immunization policies to eradicate endemic diseases. Major trends in the forecast period include focusing on development of combination vaccines, investing extensively in r&d activities, using artificial intelligence (ai) in vaccine development and focusing on strategic acquisitions.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=3453&type=smp

DTP Vaccines Market Major Segments
The dtp vaccines market covered in this report is segmented -

1) By Product type: DTaP, TD, Tdap
2) By Disease: Diphtheria, Pertussis, Tetanus
3) By End-User: Hospitals, Clinics, Vaccination Centers

Key Driver - Government Initiatives Propel Development And Adoption Of Dtp Vaccines

Governments all over the world are encouraging the development of DTP vaccines in order to prevent the spread of the disease. Countries such as India have the Universal Immunization Programme that aims to provide recommended vaccines against tuberculosis, polio, and other diseases including diphtheria, tetanus, and whooping cough for all Indian children. The country regularly conducts vaccination drives, which are expected to positively impact the growth of the market. These initiatives are expected to drive the growth of the market in the forecast period.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=3453&type=smp

Prominent Trend - Innovative In Vaccine Paving The Way For Enhanced Protection Of Adolescents, Adults, And Unborn Children

Major companies operating in the diphtheria, tetanus, and pertussis (DTP) vaccine market are focusing on developing innovative vaccines such as BOOSTRIX to gain a competitive edge in the market. BOOSTRIX is a vaccine used to help protect adolescents (ages 10-18) and adults against certain diseases caused by bacteria called Bordetella pertussis, diphtheria, and tetanus. It's a combination vaccine that helps prevent whooping cough (pertussis), diphtheria, and tetanus. For instance, in October 2022, GSK plc, a UK-based biotechnology and pharmaceutical company, launched BOOSTRIX, which received approval from the US Food and Drug Administration (FDA). This is the first vaccine that has been specifically licensed for use by pregnant women to protect unborn children from illness. It enhances the mother's antibodies, which are passed on to the growing baby when given during pregnancy.

DTP Vaccines Market Players
Major companies operating in the dtp vaccines market report are GlaxoSmithKline, Sanofi, Merck & Co Inc, Meiji Holdings Co., Ltd, Shenzhen Kangtai Biological Products, Serum Institute of India Pvt Ltd, Sun Pharmaceutical Industries Ltd, AJ Vaccines, PT Bio Farma, Bio Med, Sinergium Biotech SA, Teuto Brasileiro, Amgen, Roche, BioFabri, Sinopharm, Chongqing Zhifei, Hualan Biological Engineering Inc, Ezequiel Dias Foundation (FUNED), BioKangtai, Uniao Quimica, Valneva SE, The Abu Dhabi Health Services Company (SEHA), ImevaX GmbH, Cristalia, Bharat Biotech, Bio-Manguinhos-Institute of Technology on Immunobiologicals, Connaught Laboratories Inc, Biolab Farmaceutica, Massbiologics, Beijing Tiantan Biological Products Co Ltd, Butantan Institute, C.R.I. Kasauli, Bayer, Pfizer, Abbott Laboratories, Serum Institute of India Pvt Ltd, Novartis, Wyeth-Ayerst, Dano Vaccines, Merck Serono Middle East, Hypermarcas, AstraZeneca, Grifols, Sinovac Biotech Ltd, AbbVie Inc, Apotex, GreenSignal Bio Pharma Private Limited (GSBPL), Teva Pharmaceutical Industries Ltd F. Hoffmann-La Roche AG, Boehringer Ingelheim, CanSino Biologics, Gilead Sciences, Panacea Biotec Ltd, Fiocruz, Johnson & Johnson, Walvax biotechnology, BioNTech, EMS Pharma, Mylan, National Administration of Laboratories and Institutes of Health (ANLIS), Zentiva, Afrigen Biologics & Vaccines

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/dtp-vaccine-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the DTP vaccines market in 2023. The regions covered in the dtp vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Table Of Content For The Market Report Include:
1. Executive Summary
2. DTP Vaccines Market Report Structure
3. DTP Vaccines Market Trends And Strategies
4. DTP Vaccines Market - Macro Economic Scenario
5. DTP Vaccines Market Size And Growth
…..
27. DTP Vaccines Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.